FLT3 and acute myeloid leukemia: Considering the low mutation rate of haematopoietic stem and progenitor cells, estimated to comprise as little as one acquired exonic mutation per decade [62], as well as the relative stability of somatic variants through single AML disease courses [58, 63], it seems implausible that multiple FLT3‐ITD mutations are acquired synchronically.